🌐EnglishEnglishBahasa IndonesiaDeutschEspañolFrançaisItalianoPolskiPortuguêsTiếng ViệtTürkçeالعربيةفارسی한국어中文日本語EntityQ27888393· pop 19· linked from 1,071 articlesabiraterone acetatechemical compoundResearch1,753 papersAbiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.The Lancet. Oncology · 2019Abiraterone acetate.Drugs in R&D · 2010Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial.European urology oncology · 2025Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone.Drugs of today (Barcelona, Spain : 1998) · 2019Abiraterone acetate in the treatment of prostate cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2018via PubMedAvailable in 18 languagesEspañolFrançaisDeutsch中文日本語PortuguêsItalianoالعربيةBahasa IndonesiaCentral KurdishConnectionsDDTEntityarterial hypertensionEntityCategories11β-Hydroxylase inhibitors3-Pyridyl compounds3β-Hydroxysteroid dehydrogenase inhibitors5α-Reductase inhibitorsAcetate estersAndrostanesAntiestrogensAntiglucocorticoidsCombination cancer drugsConjugated dienesCYP17A1 inhibitorsCYP2D6 inhibitorsDrugs developed by Johnson & Johnson